213 related articles for article (PubMed ID: 2379237)
1. Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene.
Montesano R; Pepper MS; Möhle-Steinlein U; Risau W; Wagner EF; Orci L
Cell; 1990 Aug; 62(3):435-45. PubMed ID: 2379237
[TBL] [Abstract][Full Text] [Related]
2. Polyoma middle T-induced vascular tumor formation: the role of the plasminogen activator/plasmin system.
Sabapathy KT; Pepper MS; Kiefer F; Möhle-Steinlein U; Tacchini-Cottier F; Fetka I; Breier G; Risau W; Carmeliet P; Montesano R; Wagner EF
J Cell Biol; 1997 May; 137(4):953-63. PubMed ID: 9151696
[TBL] [Abstract][Full Text] [Related]
3. Perturbations in the fibrinolytic pathway abolish cyst formation but not capillary-like organization of cultured murine endothelial cells.
Dubois-Stringfellow N; Jonczyk A; Bautch VL
Blood; 1994 Jun; 83(11):3206-17. PubMed ID: 7514904
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro.
Pepper MS; Belin D; Montesano R; Orci L; Vassalli JD
J Cell Biol; 1990 Aug; 111(2):743-55. PubMed ID: 1696269
[TBL] [Abstract][Full Text] [Related]
5. Human endothelial cells expressing polyoma middle T induce tumors.
Primo L; Roca C; Ferrandi C; Lanfrancone L; Bussolino F
Oncogene; 2000 Jul; 19(32):3632-41. PubMed ID: 10951569
[TBL] [Abstract][Full Text] [Related]
6. Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment.
Williams RL; Risau W; Zerwes HG; Drexler H; Aguzzi A; Wagner EF
Cell; 1989 Jun; 57(6):1053-63. PubMed ID: 2736622
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways.
Schnaper HW; Barnathan ES; Mazar A; Maheshwari S; Ellis S; Cortez SL; Baricos WH; Kleinman HK
J Cell Physiol; 1995 Oct; 165(1):107-18. PubMed ID: 7559792
[TBL] [Abstract][Full Text] [Related]
8. Enhanced proteolytic activity is responsible for the aberrant morphogenetic development of SV40-immortalized normal human salivary gland cells grown on basement membrane components.
Azuma M; Tamatani T; Fukui K; Bando T; Sato M
Lab Invest; 1994 Feb; 70(2):217-27. PubMed ID: 8139263
[TBL] [Abstract][Full Text] [Related]
9. Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines.
Quax PH; van Leeuwen RT; Verspaget HW; Verheijen JH
Cancer Res; 1990 Mar; 50(5):1488-94. PubMed ID: 2105839
[TBL] [Abstract][Full Text] [Related]
10. Secretion of SPARC by endothelial cells transformed by polyoma middle T oncogene inhibits the growth of normal endothelial cells in vitro.
Sage EH
Biochem Cell Biol; 1992 Jul; 70(7):579-92. PubMed ID: 1449724
[TBL] [Abstract][Full Text] [Related]
11. Phorbol ester induces cultured endothelial cells to invade a fibrin matrix in the presence of fibrinolytic inhibitors.
Montesano R; Pepper MS; Vassalli JD; Orci L
J Cell Physiol; 1987 Sep; 132(3):509-16. PubMed ID: 2443514
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes.
Lijnen HR; Wagner EF; Collen D
Thromb Haemost; 1997 Feb; 77(2):362-7. PubMed ID: 9157597
[TBL] [Abstract][Full Text] [Related]
13. Murine endothelioma cell lines transformed by polyoma middle T oncogene as target for and producers of cytokines.
Bussolino F; De Rossi M; Sica A; Colotta F; Wang JM; Bocchietto E; Padura IM; Bosia A; DeJana E; Mantovani A
J Immunol; 1991 Oct; 147(7):2122-9. PubMed ID: 1918946
[TBL] [Abstract][Full Text] [Related]
14. The role of vascular endothelial cells in the regulation of fibrinolysis.
Grulich-Henn J; Müller-Berghaus G
Z Kardiol; 1989; 78 Suppl 6():25-9. PubMed ID: 2694664
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells.
Pepper MS; Ferrara N; Orci L; Montesano R
Biochem Biophys Res Commun; 1991 Dec; 181(2):902-6. PubMed ID: 1755866
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium.
Sprengers ED; Verheijen JH; Van Hinsbergh VW; Emeis JJ
Biochim Biophys Acta; 1984 Sep; 801(2):163-70. PubMed ID: 6541058
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolytic system of cultured endothelial cells: regulation by plasminogen activator inhibitor.
Loskutoff DJ; Ny T; Sawdey M; Lawrence D
J Cell Biochem; 1986; 32(4):273-80. PubMed ID: 3100541
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activators and their inhibitor gene expression in cutaneous NF1-related neurofibromas.
Sirén V; Peltonen J; Vaheri A
Arch Dermatol Res; 2006 Mar; 297(9):421-4. PubMed ID: 16408192
[TBL] [Abstract][Full Text] [Related]
19. Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene.
Williams RL; Courtneidge SA; Wagner EF
Cell; 1988 Jan; 52(1):121-31. PubMed ID: 3345558
[TBL] [Abstract][Full Text] [Related]
20. Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity.
Koolwijk P; van Erck MG; de Vree WJ; Vermeer MA; Weich HA; Hanemaaijer R; van Hinsbergh VW
J Cell Biol; 1996 Mar; 132(6):1177-88. PubMed ID: 8601593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
